Varaico: Literature-Extracted Genetic Variants

Gene:MCL1
Variant:p.S159A
Back to variants list

MCL1

NM_021960.5:p.S159A

Associated Papers

Interplay between protein acetylation and ubiquitination controls MCL1 protein stability.

Shimizu K et al.

Cell Reports, 2021

Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.

Gao F et al.

Cell Death & Disease, 2020

Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.

Ye M et al.

Cancer Research, 2017

PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation.

Wu DW et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2016

Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.

Bailey ML et al.

Genetics, 2015

Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1.

Thomas LW et al.

Plos One, 2012

Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer.

Nifoussi SK et al.

Plos One, 2012

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

Wertz IE et al.

Nature, 2011

Mcl-1 degradation during hepatocyte lipoapoptosis.

Masuoka HC et al.

The Journal of Biological Chemistry, 2009

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."